Literature DB >> 9331545

Peptidomimetic regulation of growth hormone secretion.

R G Smith1, L H Van der Ploeg, A D Howard, S D Feighner, K Cheng, G J Hickey, M J Wyvratt, M H Fisher, R P Nargund, A A Patchett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9331545     DOI： 10.1210/edrv.18.5.0316

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  83 in total

1.  Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans.

Authors:  E Arvat; L Di Vito; F Broglio; M Papotti; G Muccioli; C Dieguez; F F Casanueva; R Deghenghi; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Deletion of ghrelin impairs neither growth nor appetite.

Authors:  Yuxiang Sun; Saira Ahmed; Roy G Smith
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Growth hormone secretagogue receptor (GHS-R1a) knockout mice exhibit improved spatial memory and deficits in contextual memory.

Authors:  Rosie G Albarran-Zeckler; Alicia Faruzzi Brantley; Roy G Smith
Journal:  Behav Brain Res       Date:  2012-03-31       Impact factor: 3.332

4.  Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.

Authors:  Andras Kern; Rosie Albarran-Zeckler; Heidi E Walsh; Roy G Smith
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

5.  Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Authors:  Delphine Mousseaux; Lionel Le Gallic; Joanne Ryan; Catherine Oiry; Didier Gagne; Jean-Alain Fehrentz; Jean-Claude Galleyrand; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

6.  Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy.

Authors:  F Broglio; A Benso; M R Valetto; C Gottero; L Quaranta; V Podio; E Arvat; M Bobbio; G Bisi; E Ghigo
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

7.  Effects of cortistatin-14 and somatostatin-14 on the endocrine response to hexarelin in humans.

Authors:  A Benso; C Gottero; F Prodam; C Gauna; S Destefanis; L Filtri; A J van der Lely; R Deghenghi; E Ghigo; F Broglio
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

8.  Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

Authors:  M Gálfi; M Radács; Zs Molnár; I Budai; G Tóth; A Pósa; K Kupai; Z Szalai; R Szabó; H A Molnár; J Gardi; Ferenc A László; Cs Varga
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

9.  EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man.

Authors:  F Broglio; F Boutignon; A Benso; C Gottero; F Prodam; E Arvat; C Ghè; F Catapano; A Torsello; V Locatelli; G Muccioli; D Boeglin; V Guerlavais; J A Fehrentz; J Martinez; E Ghigo; R Deghenghi
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

10.  GH-releasing peptide (GHRP-6)-induced ACTH release in patients with addison's disease: effect of glucocorticoid withdrawal.

Authors:  M R A Martins; A C A R Pinto; E Brunner; M R D Silva; A M J Lengyel
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.